ATE272629T1 - Benzothiophene - Google Patents

Benzothiophene

Info

Publication number
ATE272629T1
ATE272629T1 AT98307627T AT98307627T ATE272629T1 AT E272629 T1 ATE272629 T1 AT E272629T1 AT 98307627 T AT98307627 T AT 98307627T AT 98307627 T AT98307627 T AT 98307627T AT E272629 T1 ATE272629 T1 AT E272629T1
Authority
AT
Austria
Prior art keywords
formula
compounds
benzothiophene
cervix
uterus
Prior art date
Application number
AT98307627T
Other languages
English (en)
Inventor
Jeffrey Alan Dodge
Mark Gregory Stocksdale
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE272629T1 publication Critical patent/ATE272629T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Bipolar Transistors (AREA)
  • Semiconductor Lasers (AREA)
AT98307627T 1997-09-23 1998-09-21 Benzothiophene ATE272629T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5962097P 1997-09-23 1997-09-23

Publications (1)

Publication Number Publication Date
ATE272629T1 true ATE272629T1 (de) 2004-08-15

Family

ID=22024136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98307627T ATE272629T1 (de) 1997-09-23 1998-09-21 Benzothiophene

Country Status (8)

Country Link
EP (1) EP0905132B1 (de)
JP (1) JP2001517664A (de)
AT (1) ATE272629T1 (de)
AU (1) AU9493698A (de)
CA (1) CA2304138A1 (de)
DE (1) DE69825381T2 (de)
ES (1) ES2226072T3 (de)
WO (1) WO1999015521A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000834A1 (en) * 2003-06-10 2005-01-06 Eli Lilly And Company Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
ES2774935T3 (es) 2012-10-24 2020-07-23 Univ Illinois Composiciones y métodos para tratar trastornos médicos relacionados con estrógeno
EP2912033A4 (de) 2012-10-24 2016-09-14 Univ Illinois Zusammensetzungen und verfahren zur behandlung östrogenvermittelter erkrankungen
GB201311888D0 (en) * 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
US20180228907A1 (en) 2014-04-14 2018-08-16 Arvinas, Inc. Cereblon ligands and bifunctional compounds comprising the same
US20180072711A1 (en) 2016-09-15 2018-03-15 Arvinas, Inc. Indole derivatives as estrogen receptor degraders
BR112019011200B1 (pt) 2016-12-01 2021-12-28 Arvinas Operations, Inc Derivados de tetrahidronaftaleno e tetrahidroisoquinolina como degradadores do receptor de estrogênio
BR112019015312A2 (pt) * 2017-01-26 2020-03-10 Arvinas Operations, Inc. Moduladores da proteólise pelo receptor de estrogênio e métodos de uso associados
IL312367A (en) 2017-01-31 2024-06-01 Arvinas Operations Inc Cereblon ligands and bifunctional compounds comprising the same
WO2019148055A1 (en) 2018-01-26 2019-08-01 Yale University Imide-based modulators of proteolysis and methods of use
KR20220054347A (ko) 2019-08-26 2022-05-02 아비나스 오퍼레이션스, 인코포레이티드 에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 유도체로 유방암을 치료하는 방법
AU2020405129A1 (en) 2019-12-19 2022-06-23 Arvinas Operations, Inc. Compounds and methods for the targeted degradation of androgen receptor
WO2022056368A1 (en) 2020-09-14 2022-03-17 Arvinas Operations, Inc. Crystalline forms of a compound for the targeted degradation of estrogen receptor
CN116813603B (zh) * 2023-06-02 2024-10-22 成都市第三人民医院 一种选择性雌激素受体α降解化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589482A (en) * 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
DE69600709T2 (de) * 1995-06-07 1999-03-18 Eli Lilly And Co., Indianapolis, Ind. Verbindungen mit N-Acyliertem Piperidin in der Seitenkette und Zusammensetzungen
US6444688B1 (en) * 1995-06-07 2002-09-03 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side chains
US5728724A (en) * 1995-08-17 1998-03-17 Eli Lilly And Company Benzothiophene compounds
WO1997030709A1 (en) * 1996-02-22 1997-08-28 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods

Also Published As

Publication number Publication date
DE69825381D1 (de) 2004-09-09
DE69825381T2 (de) 2005-07-21
ES2226072T3 (es) 2005-03-16
WO1999015521A1 (en) 1999-04-01
EP0905132B1 (de) 2004-08-04
CA2304138A1 (en) 1999-04-01
AU9493698A (en) 1999-04-12
EP0905132A1 (de) 1999-03-31
JP2001517664A (ja) 2001-10-09

Similar Documents

Publication Publication Date Title
ATE272629T1 (de) Benzothiophene
DK0615448T3 (da) Kønssteroidaktivitetsinhibitorer
DE69912606D1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate
EP1206937A4 (de) Nikroimidazolpräparationen zur äusseren anwendung zur behandlung der dermatose
EA199900937A1 (ru) Фармацевтические композиции, содержащие вориконазол
BR0213094A (pt) Derivados de cromano como ligandos de 5-hidroxi-triptamina-6
YU56995A (sh) Soli derivata indola
ES2184131T3 (es) Derivados de benzamidina y su utilizacion como medicamentos con efecto antagonista de ltb4.
DE60012988D1 (en) Taxane mit carbonaten in c-4
BR0105563A (pt) Derivados e análogos de galantamina
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DE69603886D1 (de) Alpha-substituierte 1-Benzyl-naphthyl-Derivate
FR2387955A1 (fr) Derives de l'aniline utilisables comme medicament
KR910002437A (ko) 항염증성 조성물, 항알레르기성 조성물 또는 이들 혼합성질의 조성물
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
ATE416174T1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
EP0902025A3 (de) Benzothiophene zur Behandlung von Estrogen-abhängigen Erkrankungen
ATE263164T1 (de) Bentzothiophene
ATE277913T1 (de) Bisarylderivate mit fsh rezeptor modulierender aktivität
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
ES2201152T3 (es) 3-bencil-benzotiofenos.
ATE243206T1 (de) Alpha-substituierte 3-benzyl-benzofurane
FR2429201A1 (fr) Sulfoxydes utilisables comme agents initiateurs de photopolymerisation
DE69909097D1 (de) 5-bicycloindolverbindungen
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties